文献速递泌尿生殖介入CT

小肾肿瘤经皮冷冻消融后消融后综合征的前瞻性研究:发生率、严重程度、持续时间及对生活方式的影响

Post-ablation syndrome after percutaneous cryoablation of small renal tumors: A prospective study of incidence, severity, duration, and effect on lifestyle.
PubMed 文献 · Eur J Radiol · 2019-11-13

前瞻性纳入39例患者共40次CT引导下经皮肾冷冻消融,问卷评估术后21天内发热、恶心、呕吐、乏力及对生活方式的干扰。发热发生率100%,乏力63%,恶心和呕吐各20%;96%症状在术后第2天前出现,94%在第8天前缓解,对一般活动和工作最大干扰评分均值分别为3.6和1.1。

要点

  • 肾冷冻消融后发热发生率100%,多为低热(最高等级0级24次、1级15次、2级1次)。
  • 恶心和呕吐发生率各20%,乏力63%;96%症状在术后第2天前出现。
  • 94%症状在术后第8天前自行缓解,对生活方式干扰轻微。

核心结论

  • 消融后综合征症状总体为早期出现且自限性,对生活方式影响轻微,第8天前缓解。

研究设计与样本

  • 前瞻性研究,纳入39例患者(男27例、女12例,平均年龄62岁)共40次CT引导下经皮冷冻消融,治疗病理证实的肾癌(平均大小20 mm),时间范围为2015年12月至2017年12月;采用问卷评估术后21天内症状,按不良事件常见毒性标准分级。

诊断标准与关键数值

  • 发热发生率100%(40/40),最高分级为0级(定义为≥37.0 °C且<38.0 °C)24次、1级15次、2级1次。
  • 恶心发生率20%(8/40),最高分级均为2级(8次)。
  • 呕吐发生率20%(8/40),最高分级为1级7次、3级1次。
  • 乏力发生率63%(25/40),最高分级为1级14次、2级11次。
  • 81个症状中78个(96%)在术后第2天前出现,76个(94%)在术后第8天前缓解。

临床应用与阅片要点

  • 管理接受肾冷冻消融患者的从业者应知晓消融后综合征的临床过程及影响。

局限性

  • 原文未报告局限性。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

英文原文(摘要)· 点击展开

PURPOSE: To prospectively investigate the incidence, severity, duration, and effect on lifestyle of post-ablation syndrome (PAS) after percutaneous renal cryoablation.

MATERIALS AND METHODS: We enrolled 39 patients (27 male and 12 female; mean age, 62 years) who underwent 40 CT-guided cryoablation sessions for pathologically proven renal cancer (mean size, 20 mm) between December 2015 and December 2017. Four symptoms attributable to PAS, i.e., fever, nausea, vomiting, malaise, and the synergistic effect of these symptoms on lifestyle by 21 days after ablation were evaluated using a questionnaire. Symptoms were graded according to the common toxicity criteria of adverse events.

RESULTS: The incidences of fever, nausea, vomiting, and malaise were 100% (40/40), 20% (8/40), 20% (8/40), and 63% (25/40), respectively. Most (78/81, 96%) symptoms had begun by day 2. The highest grade of fever per session was 0 (defined as ≥37.0 °C and <38.0 °C) (n = 24), 1 (n = 15), or 2 (n = 1); that of nausea was 2 (n = 8); that of vomiting was 1 (n = 7) or 3 (n = 1); and that of malaise was 1 (n = 14) or 2 (n = 11). Most (76/81, 94%) symptoms had resolved by day 8. The average values for the maximum scores of interference with general activity and work were 3.6 and 1.1, respectively.

CONCLUSION: All symptoms were generally early-onset and self-limiting, with minimal impact on lifestyle and resolution by day 8. The clinical course and impact of PAS should be acknowledged by practitioners who manage patients undergoing renal cryoablation.

来源:Eur J Radiol,查看原文。版权归原作者所有。

引用

  1. Kawabata T, Hiraki T, Iguchi T, et al. Post-ablation syndrome after percutaneous cryoablation of small renal tumors: A prospective study of incidence, severity, duration, and effect on lifestyle. Eur J Radiol. 2019. PMID: 31790935. doi:10.1016/j.ejrad.2019.108750

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。